0002001011-24-000052.txt : 20240515 0002001011-24-000052.hdr.sgml : 20240515 20240515193453 ACCESSION NUMBER: 0002001011-24-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Korenberg Matthew E CENTRAL INDEX KEY: 0001649903 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 24953209 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-05-13 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001649903 Korenberg Matthew E 555 HERITAGE DRIVE SUITE 200 JUPITER FL 33458 0 1 0 0 President & Chief Operating 0 Common Stock 2024-05-13 4 S 0 3440 84.5431 D 100421 D Common Stock 2024-05-14 4 S 0 13638 85.0826 D 86783 D Common Stock 2024-05-14 4 S 0 520 85.6841 D 86263 D The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5000 to $84.8750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5950 to $85.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.6250 to $85.7650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. By: /s/ Andrew Reardon, Attorney-in-Fact For: Matthew E. Korenberg 2024-05-15